Cover Image
Market Research Report
Product code 
1029020

Global Conjunctivitis Therapeutics Market 2021-2025

Published: | TechNavio (Infiniti Research Ltd.) | 120 Pages | Delivery time: 1-2 business days

Price

Back to Top
Global Conjunctivitis Therapeutics Market 2021-2025
Published: July 9, 2021
TechNavio (Infiniti Research Ltd.)
Content info: 120 Pages
Delivery time: 1-2 business days
  • Description
  • Table of Contents

Technavio has been monitoring the conjunctivitis therapeutics market and it is poised to grow by $ 622.71 mn during 2021-2025, progressing at a CAGR of over 3% during the forecast period. Our report on the conjunctivitis therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increase in the adoption rate of therapeutics and increasing prevalence of allergies and their associated risks. In addition, increase in the adoption rate of therapeutics is anticipated to boost the growth of the market as well.

The conjunctivitis therapeutics market analysis includes the type segment and geographic landscape.

Technavio's conjunctivitis therapeutics market is segmented as below:

By Type

  • Allergic conjunctivitis
  • Bacterial conjunctivitis
  • Viral conjunctivitis

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • ROW

This study identifies the advances in treatment optionsas one of the prime reasons driving the conjunctivitis therapeutics market growth during the next few years.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on conjunctivitis therapeutics market covers the following areas:

  • Conjunctivitis therapeutics market sizing
  • Conjunctivitis therapeutics market forecast
  • Conjunctivitis therapeutics market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading conjunctivitis therapeutics market vendors that include AbbVie Inc., Akorn Inc., Bausch Health Companies Inc., Merck and Co. Inc., NovaBay Pharmaceuticals Inc., Novartis AG, Pfizer Inc., Santen Pharmaceutical Co. Ltd., Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd. Also, the conjunctivitis therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR70759

Table of Contents

  • Executive Summary
    • Market overview
  • Market Landscape
    • Market ecosystem
    • Value chain analysis
  • Market Sizing
    • Market definition
    • Market segment analysis
    • Market size 2020
    • Market outlook: Forecast for 2020 - 2025
  • Five Forces Analysis
    • Bargaining power of buyers
    • Bargaining power of suppliers
    • Threat of new entrants
    • Threat of substitutes
    • Threat of rivalry
    • Market condition
  • Market Segmentation by Type
    • Market segments
    • Comparison by Type
    • Allergic conjunctivitis - Market size and forecast 2020-2025
    • Bacterial conjunctivitis - Market size and forecast 2020-2025
    • Viral conjunctivitis - Market size and forecast 2020-2025
    • Market opportunity by Type
  • Customer landscape
    • Customer landscape
  • Geographic Landscape
    • Geographic segmentation
    • Geographic comparison
    • North America - Market size and forecast 2020-2025
    • Europe - Market size and forecast 2020-2025
    • Asia - Market size and forecast 2020-2025
    • ROW - Market size and forecast 2020-2025
    • Key leading countries
    • Market opportunity By Geographical Landscape
    • Market drivers
    • Market challenges
    • Market trends
  • Vendor Landscape
    • Vendor landscape
    • Landscape disruption
    • Overview
  • Vendor Analysis
    • Vendors covered
    • Market positioning of vendors
    • AbbVie Inc.
    • Akorn Inc.
    • Bausch Health Companies Inc.
    • Merck and Co. Inc.
    • NovaBay Pharmaceuticals Inc.
    • Novartis AG
    • Pfizer Inc.
    • Santen Pharmaceutical Co. Ltd.
    • Sun Pharmaceutical Industries Ltd.
    • Teva Pharmaceutical Industries Ltd.
  • Appendix
    • Scope of the report
    • Currency conversion rates for US$
    • Research methodology
    • List of abbreviations

Exhibits

  • 1: Key Finding 1
  • 2: Key Finding 2
  • 3: Key Finding 3
  • 4: Key Finding 5
  • 5: Key Finding 6
  • 6: Key Finding 7
  • 7: Key Finding 8
  • 8: Parent market
  • 9: Market characteristics
  • 10: Offerings of vendors included in the market definition
  • 11: Market segments
  • 12: Global - Market size and forecast 2020 - 2025 ($ million)
  • 13: Global market: Year-over-year growth 2020 - 2025 (%)
  • 14: Five forces analysis 2020 & 2025
  • 15: Bargaining power of buyers
  • 16: Bargaining power of suppliers
  • 17: Threat of new entrants
  • 18: Threat of substitutes
  • 19: Threat of rivalry
  • 20: Market condition - Five forces 2020
  • 21: Type - Market share 2020-2025 (%)
  • 22: Comparison by Type
  • 23: Allergic conjunctivitis - Market size and forecast 2020-2025 ($ million)
  • 24: Allergic conjunctivitis - Year-over-year growth 2020-2025 (%)
  • 25: Bacterial conjunctivitis - Market size and forecast 2020-2025 ($ million)
  • 26: Bacterial conjunctivitis - Year-over-year growth 2020-2025 (%)
  • 27: Viral conjunctivitis - Market size and forecast 2020-2025 ($ million)
  • 28: Viral conjunctivitis - Year-over-year growth 2020-2025 (%)
  • 29: Market opportunity by Type
  • 30: Customer landscape
  • 31: Market share By Geographical Landscape 2020-2025 (%)
  • 32: Geographic comparison
  • 33: North America - Market size and forecast 2020-2025 ($ million)
  • 34: North America - Year-over-year growth 2020-2025 (%)
  • 35: Europe - Market size and forecast 2020-2025 ($ million)
  • 36: Europe - Year-over-year growth 2020-2025 (%)
  • 37: Asia - Market size and forecast 2020-2025 ($ million)
  • 38: Asia - Year-over-year growth 2020-2025 (%)
  • 39: ROW - Market size and forecast 2020-2025 ($ million)
  • 40: ROW - Year-over-year growth 2020-2025 (%)
  • 41: Key leading countries
  • 42: Market opportunity By Geographical Landscape ($ million)
  • 43: Impact of drivers and challenges
  • 44: Vendor landscape
  • 45: Landscape disruption
  • 46: Industry risks
  • 47: Vendors covered
  • 48: Market positioning of vendors
  • 49: AbbVie Inc. - Overview
  • 50: AbbVie Inc. - Product and service
  • 51: AbbVie Inc. - Key offerings
  • 52: AbbVie Inc. - Key customers
  • 53: AbbVie Inc. - Segment focus
  • 54: Akorn Inc. - Overview
  • 55: Akorn Inc. - Product and service
  • 56: Akorn Inc. - Key offerings
  • 57: Akorn Inc. - Key customers
  • 58: Akorn Inc. - Segment focus
  • 59: Bausch Health Companies Inc. - Overview
  • 60: Bausch Health Companies Inc. - Business segments
  • 61: Bausch Health Companies Inc. - Key offerings
  • 62: Bausch Health Companies Inc. - Key customers
  • 63: Bausch Health Companies Inc. - Segment focus
  • 64: Merck and Co. Inc. - Overview
  • 65: Merck and Co. Inc. - Business segments
  • 66: Merck and Co. Inc. - Key offerings
  • 67: Merck and Co. Inc. - Key customers
  • 68: Merck and Co. Inc. - Segment focus
  • 69: NovaBay Pharmaceuticals Inc.- Overview
  • 70: NovaBay Pharmaceuticals Inc.- Product and service
  • 71: NovaBay Pharmaceuticals Inc.- Key offerings
  • 72: NovaBay Pharmaceuticals Inc.- Key customers
  • 73: NovaBay Pharmaceuticals Inc.- Segment focus
  • 74: Novartis AG - Overview
  • 75: Novartis AG - Business segments
  • 76: Novartis AG - Key offerings
  • 77: Novartis AG - Key customers
  • 78: Novartis AG - Segment focus
  • 79: Pfizer Inc. - Overview
  • 80: Pfizer Inc. - Business segments
  • 81: Pfizer Inc. - Key offerings
  • 82: Pfizer Inc. - Key customers
  • 83: Pfizer Inc. - Segment focus
  • 84: Santen Pharmaceutical Co. Ltd. - Overview
  • 85: Santen Pharmaceutical Co. Ltd. - Business segments
  • 86: Santen Pharmaceutical Co. Ltd. - Key offerings
  • 87: Santen Pharmaceutical Co. Ltd. - Key customers
  • 88: Santen Pharmaceutical Co. Ltd. - Segment focus
  • 89: Sun Pharmaceutical Industries Ltd. - Overview
  • 90: Sun Pharmaceutical Industries Ltd. - Business segments
  • 91: Sun Pharmaceutical Industries Ltd. - Key offerings
  • 92: Sun Pharmaceutical Industries Ltd. - Key customers
  • 93: Sun Pharmaceutical Industries Ltd. - Segment focus
  • 94: Teva Pharmaceutical Industries Ltd. - Overview
  • 95: Teva Pharmaceutical Industries Ltd. - Business segments
  • 96: Teva Pharmaceutical Industries Ltd. - Key offerings
  • 97: Teva Pharmaceutical Industries Ltd. - Key customers
  • 98: Teva Pharmaceutical Industries Ltd. - Segment focus
  • 99: Currency conversion rates for US$
  • 100: Research Methodology
  • 101: Validation techniques employed for market sizing
  • 102: Information sources
  • 103: List of abbreviations